fashion -WSS

fashion

author：fashion 2025-09-01 15:16:39 - browse：61

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter:

Novo Nordiskis conducting a large clinical trial to prove that its GLP-1 drug Wegovy, in addition to helping people lose weight, also improves cardiovascular health. The SELECT study enrolled 17,500 participants who had overweight or obesity and had preexisting heart disease. The participants were then randomized to receive weekly injections of Wegovy or a matching placebo. The primary goal is to determine the extent to which Wegovy reduces the risk of heart attacks, strokes, and heart-related deaths. Wegovy is already a blockbuster drug based on weight loss alone, but proving an additional cardiovascular benefit could open the commercial floodgates.

BridgeBiowill report in July an analysis of all-cause mortality from a clinical trial of its heart drug acoramidis. The outcome is an important, second attempt at demonstrating benefit for acoramidis in a progressive heart disease called ATTR-CM. In December 2021, the drug performed no better than a placebo on a test of how far study participants could walk over the course of six minutes, failing to achieve its primary goal. But in this second part of the same study, BridgeBio will determine if acoramidis can significantly reduce hospitalizations and death over the course of 30 months.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Moonlake's readout produced a cash windfall. Risks remain

entertainment

explore

WSS

United colonoscopy coverage change 'may cost lives,' doctors say

Alkermes shareholders re

MoonLake credibility takes another hit with mid

Ambulance rides for just $100? Advisers want major billing fixes

Ambulance rides for just $100? Advisers want major billing fixes

Drug repurposing or repositioning? The language matters

focus

fashion

focus

Trump demands the U.S. pay no more for drugs than other countries … again

Excited delirium, Elijah McClain, and emergency physicians

Medical records are filled with copy

Trump demands the U.S. pay no more for drugs than other countries … again

Guidelines to prevent youth baseball injuries need more muscle

Walensky prepares to leave CDC — and Congress — behind

In Memoriam: Notable people who died in 2023

Excited delirium, Elijah McClain, and emergency physicians

Tori Bowie and the unacceptable rates of Black maternal death

Drug repurposing or repositioning? The language matters

leisure time

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

ChatGPT in medicine: STAT answers readers' burning questions

Sanofi CEO defends move to abandon profit guidance, boost research

Medicare solvency divides Republicans at the presidential debate

HPV cancer vaccine study demonstrates efficacy

Activists slam private health insurers over coverage restrictions

hotspot

entertainment

explore

hotspot